Badaki-Makun, Oluwakemi
Levin, Scott
Debraine, Arnaud
Hernried, Benjamin
Malinovska, Alexandra
Smith, Aria
Toerper, Matthew
Fenstermacher, Katherine Z. J.
Cottle, Taylor
Latallo, Malgorzata
Rothman, Richard E.
Hinson, Jeremiah S.
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R18 HS02664002)
Beckman Coulter Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Gottfried und Julia Bangerter-Rhyner-Stiftung
Deutscher Akademischer Austauschdienst
Article History
Received: 4 March 2022
Accepted: 23 November 2022
First Online: 13 December 2022
Competing interests
: StoCastic (JH, AD, MT, SL) was collaborating with Beckman Coulter on integrating data-driven clinical decision support (CDS) with biomarkers measured by Beckman Coulter devices, including MDW, during the study period. JH, MT, and SL and Johns Hopkins University held equity ownership in Stocastic. During the post-peer review revision process, Stocastic was acquired by Beckman Coulter. While no CDS was directly studied, this research could underpin the development of CDS in the future. These authors and the University are entitled to royalty distributions related to CDS technology that may be created. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with conflict-of-interest policies. No other authors have competing interests.